logo True scholar network
Back to Top
Visit Website

Clinical & Translational Immunology (CTI)

Publisher :

John Wiley & Sons Inc

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Nursing
  • cell biology
  • Immunology

    • +2

e-ISSN :

2050-0068

Issue Frequency :

Monthly

Impact Factor :

5.8

Est. Year :

2012

Mobile :

0395866095

Country :

Australia

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

cti.office@unimelb.edu.au

Journal Descriptions

Clinical & Translational Immunology seeks to cover basic, translational and clinical studies in all aspects of human immunology, including experimental models specific to human diseases. Topics of particular interest within the journal’s scope include, but are not limited to, those listed below: -cutting edge approaches including in vivo models of human disease that shed light on the mechanisms of immunity -clinical studies with relevance to autoimmunity transplantation and tumor immunotherapy -cutting edge immunoassays for monitoring clinical trials/patient responses -infection and immunity - correlates of protection -immunotherapies in relation to autoimmunity, primary and secondary immunodeficiencies, --complement disorders and allergies -pathogenesis and correlates of protection for autoimmune and endocrine disorders, infectious --disease, malignancy and transplantation


Clinical & Translational Immunology (CTI) is :

International, Peer-Reviewed, Open Access, Refereed, Nursing, cell biology, Immunology, Allergy, Microbiology , Online Monthly Journal

UGC Approved, ISSN Approved: P-ISSN , E-ISSN - 2050-0068, Established in - 2012, Impact Factor - 5.8

Not Provide Crossref DOI

Indexed in Scopus, DOAJ, PubMed

Not indexed in WoS, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
DOAJ
Scopus Profile
PubMed

+6 More

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile